Use of low-molecular-weight heparin in COVID-19 patients
- PMID: 32561464
- PMCID: PMC7297673
- DOI: 10.1016/j.jvsv.2020.06.006
Use of low-molecular-weight heparin in COVID-19 patients
Comment in
-
Reply.J Vasc Surg Venous Lymphat Disord. 2020 Sep;8(5):901. doi: 10.1016/j.jvsv.2020.06.007. Epub 2020 Jul 12. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32663524 Free PMC article. No abstract available.
Comment on
-
Upsurge of deep venous thrombosis in patients affected by COVID-19: Preliminary data and possible explanations.J Vasc Surg Venous Lymphat Disord. 2020 Jul;8(4):694-695. doi: 10.1016/j.jvsv.2020.04.004. Epub 2020 Apr 17. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32305586 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical